Foot-and-mouth disease virus assembly: Processing of recombinant capsid precursor by exogenous protease induces self-assembly of pentamers in vitro in a myristoylation-dependent manner

Journal of Virology

Volumn 83, Issue 21, 2009, Pages 11275-11282

  Goodwin, Stewart ^a   Tuthill, Tobias J ^a   Arias, Armando ^b   Killington, Richard A ^a   Rowlands, David J ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHAVBETA6 INTEGRIN; CAPSID PROTEIN; CELL RECEPTOR; INTEGRIN RECEPTOR; MONOCLONAL ANTIBODY; PROTEIN 3C; PROTEIN PRECURSOR; PROTEIN VP4; PROTEINASE; RECOMBINANT CAPSID PRECURSOR PROTEIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANTIGENICITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; ESCHERICHIA COLI; FOOT AND MOUTH DISEASE VIRUS; IN VITRO STUDY; MYRISTYLATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; RECEPTOR BINDING; SUCROSE GRADIENT; VIRION; VIRUS ASSEMBLY; VIRUS CAPSID;

ANIMALS; CAPSID; CAPSID PROTEINS; FOOT-AND-MOUTH DISEASE VIRUS; MYRISTIC ACIDS; PROTEIN CONFORMATION; PROTEIN PRECURSORS; PROTEIN SUBUNITS; RECOMBINANT PROTEINS; VIRUS ASSEMBLY;

ESCHERICHIA COLI; FOOT-AND-MOUTH DISEASE VIRUS; MIRIDAE;

EID: 70350312842     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01263-09     Document Type: Article

References (60)

1. Abrams, C. C., A. M. King, and G. J. Belsham. 1995. Assembly of foot-and-mouth disease virus empty capsids synthesized by a vaccinia virus expression system. J. Gen. Virol. 76:3089-3098.
2. Ansardi, D. C., and C. D. Morrow. 1995. Amino acid substitutions in the poliovirus maturation cleavage site affect assembly and result in accumulation of provirions. J. Virol. 69:1540-1547.
3. Ansardi, D. C., D. C. Porter, and C. D. Morrow. 1991. Coinfection with recombinant vaccinia viruses expressing poliovirus P1 and P3 proteins results in polyprotein processing and formation of empty capsid structures. J. Virol. 65:2088-2092.
4. Ansardi, D. C., D. C. Porter, and C. D. Morrow. 1992. Myristylation of poliovirus capsid precursor P1 is required for assembly of subviral particles. J. Virol. 66:4556-4563.
5. Basavappa, R., R. Syed, O. Flore, J. P. Icenogle, D. J. Filman, and J. M. Hogle. 1994. Role and mechanism of the maturation cleavage of VP0 in poliovirus assembly: structure of the empty capsid assembly intermediate at 2.9 A resolution. Protein Sci. 3:1651-1669. (Pubitemid 24356589)
6. Bentham, M., S. Mazaleyrat, and M. Harris. 2006. Role of myristoylation and N-terminal basic residues in membrane association of the human immunodeficiency virus type 1 Nef protein. J. Gen. Virol. 87:563-571.
7. 6-mediated cell entry of foot-and-mouth disease virus. J. Virol. 79:8519-8534.
8. Birtley, J. R., S. R. Knox, A. M. Jaulent, P. Brick, R. J. Leatherbarrow, and S. Curry. 2005. Crystal structure of foot-and-mouth disease virus 3C protease. New insights into catalytic mechanism and cleavage specificity. 280:11520-11527.
9. Birtley, J. R., and S. Curry. 2005. Crystallization of foot-and-mouth disease virus 3C protease: surface mutagenesis and a novel crystal-optimization strategy. Acta Crystallogr D 61:646-650.
10. Bishop, N. E., and D. A. Anderson. 1997. Hepatitis A virus subviral particles: purification, accumulation, and relative infectivity of virions, provirions and procapsids. Arch. Virol. 142:2147-2160.
11. Cartwright, B. 1962. A study of the antibodies in guinea pigs infected with foot-and-mouth disease virus. J. Immunol. 88:128-133.
12. Cartwright, B., W. G. Chapman, and F. Brown. 1980. Serological and immunological relations between the 146S and 12S particles of foot-and-mouth disease virus. J. Gen. Virol. 50:369-375.
13. Chow, M., J. F. Newman, D. Filman, J. M. Hogle, D. J. Rowlands, and F. Brown. 1987. Myristylation of picornavirus capsid protein VP4 and its structural significance. Nature 327:482-486. (Pubitemid 17085817)
14. Chung, Y. C., J. H. Huang, C. W. Lai, H. C. Sheng, S. R. Shih, M. S. Ho, and Y. C. Hu. 2006. Expression, purification and characterization of enterovirus-71 virus-like particles. World J. Gastroenterol. 12:921-927.
15. Cohen, L., D. Benichou, and A. Martin. 2002. Analysis of deletion mutants indicates that the 2A polypeptide of hepatitis A virus participates in virion morphogenesis. J. Virol. 76:7495-7505. (Pubitemid 34760972)
16. Curry, S., C. S. Abrams, E. Fry, J. S. Crowther, and G. J. Belsham, D. I. Stuart, and A. M. King. 1995. Viral RNA modulates the acid sensitivity of foot-and-mouth disease virus capsids. J. Virol. 69:430-438. (Pubitemid 24378821)
17. Curry, S., E. Fry, W. Blakemore, R. Abu-Ghazaleh, T. Jackson, A. King, S. Lea, J. Newman, and D. Stuart. 1997. Dissecting the roles of VP0 cleavage and RNA packaging in picornavirus capsid stabilization: the structure of empty capsids of foot-and-mouth disease virus. J. Virol. 71:9743-9752. (Pubitemid 27492423)
18. Davis, M. P., G. Bottley, L. P. Beales, R. A. Killington, D. J. Rowlands, and T. J. Tuthill. 2008. Recombinant VP4 of human rhinovirus induces permeability in model membranes. J. Virol. 82:4169-4174.
19. Dennis, C. A., A. Baron, J. G. Grossmann, S. Mazaleyrat, M. Harris, and J. Jaeger. 2005. Co-translational myristoylation alters the quaternary structure of HIV-1 Nef in solution. Proteins 60:658-669.
20. 6: implications for infectiousness. J. Virol. 82:1537-1546.
21. Duronio, R. J., E. Jackson-Machelski, R. O. Heuckeroth, P. O. Olins, C. S. Devine, W. Yonemoto, L. W. Slice, S. S. Taylor, and J. I. Gordon. 1990. Protein N-myristoylation in Escherichia coli: reconstitution of a eukaryotic protein modification in bacteria. Proc. Natl. Acad. Sci. USA 87:1506-1510.
22. Ellard, F. M., J. Drew, W. Blakemore, D. Stuart, and A. M. King. 1999. Evidence for the role of His-142 of protein 1C in the acid-induced disassembly of foot-and-mouth disease virus capsids. J. Gen. Virol. 80:1911-1918.
23. Francis, M. J., G. Z. Hastings, B. E. Clarke, A. L. Brown, C. R. Beddell, D. J. Rowlands, and F. Brown. 1990. Neutralizing antibodies to all seven serotypes of foot-and-mouth disease virus elicited by synthetic peptides. Immunology 69:171-176. (Pubitemid 20076482)
24. Fry, E. E., D. I. Stuart, and D. J. Rowlands. 2005. The structure of foot-and-mouth disease virus. Curr. Top. Microbiol. Immunol. 288:71-101.
25. Grubman, M. J. 1984. In vitro morphogenesis of foot-and-mouth disease virus. J. Virol. 49:760-765.
26. Hindiyeh, M., Q. H. Li, R. Basavappa, J. M. Hogle, and M. Chow. 1999. Poliovirus mutants at histidine 195 of VP2 do not cleave VP0 into VP2 and VP4. J. Virol. 73:9072-9079. (Pubitemid 29487060)
27. Hogle, J. M., M. Chow, and D. J. Filman. 1985. Three-dimensional structure of poliovirus at 2.9 A resolution. Science 229:1358-1365.
28. 6 is a receptor for foot-and-mouth disease virus. J. Virol. 76:935-941.
29. 6 is a receptor for foot-and-mouth disease virus. J. Virol. 74:4949-4956.
30. Jore, J. P., G. Veldhuisen, P. H. Pouwels, A. Boeye, R. Vrijsen, and B. Rombaut. 1991. Formation of subviral particles by in vitro translation of subgenomic poliovirus RNAs. J. Gen. Virol. 72:2721-2726.
31. Kamata, T., M. Handa, Y. Sato, Y. Ikeda, and S. Aiso. 2005. Membrane-proximal a/b stalk interactions differentially regulate integrin activation. J. Biol. Chem. 280:24775-24783.
32. Knipe, T., E. Rieder, B. Baxt, G. Ward, and P. W. Mason. 1997. Characterization of synthetic foot-and-mouth disease virus provirions separates acid-mediated disassembly from infectivity. J. Virol. 71:2851-2856. (Pubitemid 27119925)
33. Lee, W. M., S. S. Monroe, and R. R. Rueckert. 1993. Role of maturation cleavage in infectivity of picornaviruses: activation of an infectosome. J. Virol. 67:2110-2122.
34. Lewis, S. A., D. O. Morgan, and M. J. Grubman. 1991. Expression, processing, and assembly of foot-and-mouth disease virus capsid structures in heterologous systems: induction of a neutralizing antibody response in guinea pigs. J. Virol. 65:6572-6580.
35. Longhurst, C. M., and L. K. Jennings. 1998. Integrin-mediated signal transduction. Cell. Mol. Life Sci. 54:514-526.
36. Marc, D., M. Girard, and S. van der Werf. 1991. A Gly1 to Ala substitution in poliovirus capsid protein VP0 blocks its myristoylation and prevents viral assembly. J. Gen. Virol. 72:1151-1157.
37. Marc, D., G. Masson, M. Girard, and S. van der Werf. 1990. Lack of myristoylation of poliovirus capsid polypeptide VP0 prevents the formation of virions or results in the assembly of noninfectious virus particles. J. Virol. 64:4099-4107. (Pubitemid 20279815)
38. Mateu, M. G., J. Da Silva, E. Rocha, D. L. De Brum, A. Alonso, L. Enjuanes, E. Domingo, and H. Barahona. 1988. Extensive antigenic heterogeneity of foot-and-mouth disease virus of serotype C. Virology 167:113-124.
39. Mateu, M. G., J. Hernandez, M. A. Martinez, D. Feigelstock, S. Lea, J. J. Perez, E. Giralt, D. Stuart, E. L. Palma, and E. Domingo. 1994. Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites. J. Virol. 68:1407-1417.
40. Mateu, M. G., M. A. Martinez, L. Capucci, D. Andreu, E. Giralt, F. Sobrino, E. Brocchi, and E. Domingo. 1990. A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C. J. Gen. Virol. 71:629-637.
41. Mateu, M. G., E. Rocha, O. Vicente, F. Vayreda, C. Navalpotro, D. Andreu, E. Pedroso, E. Giralt, L. Enjuanes, and E. Domingo. 1987. Reactivity with monoclonal antibodies of viruses from an episode of foot-and-mouth disease. Virus Res. 8:261-274.
42. Morace, G., Y. Kusov, G. Dzagurov, F. Beneduce, and V. Gauss-Muller. 2008. The unique role of domain 2A of the hepatitis A virus precursor polypeptide P1-2A in viral morphogenesis. BMB Rep. 41:678-683.
43. Moscufo, N., J. Simons, and M. Chow. 1991. Myristoylation is important at multiple stages in poliovirus assembly. J. Virol. 65:2372-2380.
44. Onodera, S., and B. A. Phillips. 1987. A novel method for obtaining poliovirus 14 S pentamers from procapsids and their self-assembly into virus-like shells. Virology 159:278-287. (Pubitemid 17143934)
45. Palmenberg, A. C. 1982. In vitro synthesis and assembly of picornaviral capsid intermediate structures. J. Virol. 44:900-906.
46. Palmenberg, A. C. 1990. Proteolytic Processing of Picornaviral Polyprotein. Annu. Rev. Microbiol. 44:603-623.
47. Parry, N. G., G. Fox, D. Rowlands, F. Brown, F. Fry, R. Acharay, D. Logan, and D. Stuart. 1990. Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus. Nature 347:569-572. (Pubitemid 20341550)
48. Paul, A. V., A. Schultz, S. E. Pincus, S. Oroszlan, and E. Wimmer. 1987. Capsid protein VP4 of poliovirus is N-myristoylated. Proc. Natl. Acad. Sci. USA 84:7827-7831.
49. Perlin, M., and B. A. Phillips. 1975. In vitro assembly of polioviruses. IV. Evidence for the existence of two assembly steps in the formation of empty capsids from 14 S particles. Virology 63:505-511.
50. Phillips, B. A. 1971. In vitro assembly of poliovirus. II. Evidence for the self-assembly of 14 S particles into empty capsids. Virology 44:307-316.
51. Probst, C., M. Jecht, and V. Gauss-Muller. 1999. Intrinsic signals for the assembly of hepatitis A virus particles. Role of structural proteins VP4 and 2A. J. Biol. Chem. 274:4527-4531.
52. Rebel, J. M., C. H. Leendertse, A. Dekker, and R. J. Moormann. 2003. Effects of mutations in the VP2/VP4 cleavage site of swine vesicular disease virus on RNA encapsidation and viral infectivity. Arch. Virol. 148:1747-1756.
53. Rombaut, B., K. Andries, and A. Boeye. 1991. A comparison of WIN 51711 and R 78206 as stabilizers of poliovirus virions and procapsids. J. Gen. Virol. 72:2153-2157.
54. Rombaut, B., A. Foriers, and A. Boeye. 1991. In vitro assembly of poliovirus 14 S subunits: identification of the assembly promoting activity of infected cell extracts. Virology 180:781-787.
55. Rombaut, B., and J. P. Jore. 1997. Immunogenic, non-infectious polio subviral particles synthesized in Saccharomyces cerevisiae. J. Gen. Virol. 78:1829-1832.
56. Rowlands, D. J., B. E. Clarke, A. R. Carroll, F. Brown, B. H. Nicholson, J. L. Bittle, R. A. Houghten, and R. A. Lerner. 1983. Chemical basis of antigenic variation in foot-and-mouth disease virus. Nature 306:694-697.
57. Rowlands, D. J., D. V. Sangar, and F. Brown. 1975. A comparative chemical and serological study of the full and empty particles of foot-and mouth disease virus. J. Gen. Virol. 26:227-238.
58. Rweyemamu, M. M., G. Terry, and T. W. Pay. 1979. Stability and immunogenicity of empty particles of foot-and-mouth disease virus. Arch. Virol. 59:69-79.
59. Saiz, J. C., J. Cairo, M. Medina, D. Zuidema, C. Abrams, G. J. Belsham, E. Domingo, and J. M. Vlak. 1994. Unprocessed foot-and-mouth disease virus capsid precursor displays discontinuous epitopes involved in viral neutralization. J. Virol. 68:4557-4564.
60. Toja, M., C. Escarmis, and E. Domingo. 1999. Genomic nucleotide sequence of a foot-and-mouth disease virus clone and its persistent derivatives. Implications for the evolution of viral quasispecies during a persistent infection. Virus Res. 64:161-171.